🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsRetatrutide & Triple AgonistsGlucagon receptor agonism and hepatic lipid oxidation — 6 month update Page 3

Glucagon receptor agonism and hepatic lipid oxidation — 6 month update

JennaRN Fri, Aug 30, 2024 at 5:22 AM 12 replies 2,000 viewsPage 3 of 3
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Sep 2, 2024 at 5:16 AM#11
PharmHunterJen said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

Ask again with the specifics and you will get a better answer than this one.

12 10steve_okc, dave_SLC, FDA_TrackerJim and 9 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Sep 3, 2024 at 12:40 PM#12
SaraMom3 said:
Agreed, and the adaptation point cuts both ways: tachyphylaxis to gastric emptying is why tolerability improves, and it is also why people who were…

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Taking it to my next appointment.

Last edited: Sep 3, 2024 at 6:40 PM
13 11ricardo_MIA, BrianDallas92, labquiet_amy and 10 others
Reply Quote Save Share Report
rick_sfbay
Member
289
1,234
Jan 2025
San Francisco, CA
Sep 4, 2024 at 8:03 PM#13
PharmHunterJen said:
There is a difference between no evidence and evidence of no effect, and this subject is one where the two get swapped freely in both directions.

I am going to disagree with the direction of travel here. The thread has converged on the tidiest answer rather than the best-supported one, and those are not the same thing.

Worth separating that from the pharmacology, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.

14 12james_edin, FranDenver, Dr.BariatricHTX and 11 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

GL Biochem (Shanghai) Ltd. — Direct Manufacturer

Est. 1998. The synthesis house behind the vials you send for testing. ISO 9001 and cGMP certified, 1,500+ staff, batch-specific COA with every order.

Browse GL Biochem
TirzTom
Senior Member
2,789
9,876
Feb 2024
Florida
Online
Sep 6, 2024 at 3:25 AM#14

Adding the numbers, since they settle part of this. If you are comparing against somebody else’s result, check that you are comparing the same measurement taken the same way. Most of the apparent contradictions in these threads dissolve at that step.

15 13SandraNC_45, Dr.EndoIndy, tom_AK and 12 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Sep 7, 2024 at 10:47 AM#15

Moderator note: the sourcing question belongs in the vendor section and has been split out. Tagging this one for the weekly digest.

16 14PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 13 others
Reply Quote Save Share Report

Similar Threads

TRIUMPH-3 topline results — 24.2% body weight loss at 48 weeks10 replies
Retatrutide mechanism: GLP-1/GIP/glucagon triple agonism explained5 replies
Retatrutide Phase 2 dose-response analysis — optimal dose range10 replies
Glucagon receptor agonism and hepatic lipid oxidation — MASH implications13 replies
Retatrutide vs tirzepatide — dual vs triple agonist comparison22 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register